Logo
x

Search

Subscribe Now

XLRP

PharmaShots Interview: Janssen's Nan Li Shares Insights on the Data Presented at ISPOR 2021

PharmaShots Interview: Janssen's Nan Li Shares Insights on the Data Presented at ISPOR 2021

  • June 21, 2021
Biogen's BIIB112 (cotoretigene toliparvovec) Fails to Meet its Primary Endpoint in P-II/III XIRIUS Study for XLRP

Biogen's BIIB112 (cotoretigene toliparvovec) Fails to Meet its Primary Endpoint in P-II/III XIRIUS Study for XLRP

  • May 17, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.